Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;197(6):570-573.
doi: 10.1007/s00066-021-01765-6. Epub 2021 Mar 25.

[Aggressive radiotherapy de-escalation for HPV-associated oropharyngeal carcinoma based on hypoxia dynamics]

[Article in German]
Alexander Rühle  1   2 , Nils H Nicolay  3   4
Affiliations
Comment

[Aggressive radiotherapy de-escalation for HPV-associated oropharyngeal carcinoma based on hypoxia dynamics]

[Article in German]
Alexander Rühle et al. Strahlenther Onkol. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.
    Riaz N, Sherman E, Pei X, Schöder H, Grkovski M, Paudyal R, Katabi N, Selenica P, Yamaguchi TN, Ma D, Lee SK, Shah R, Kumar R, Kuo F, Ratnakumar A, Aleynick N, Brown D, Zhang Z, Hatzoglou V, Liu LY, Salcedo A, Tsai CJ, McBride S, Morris LGT, Boyle J, Singh B, Higginson DS, Damerla RR, Paula ADC, Price K, Moore EJ, Garcia JJ, Foote R, Ho A, Wong RJ, Chan TA, Powell SN, Boutros PC, Humm JL, Shukla-Dave A, Pfister D, Reis-Filho JS, Lee N. Riaz N, et al. J Natl Cancer Inst. 2021 Jun 1;113(6):742-751. doi: 10.1093/jnci/djaa184. J Natl Cancer Inst. 2021. PMID: 33429428 Free PMC article. Clinical Trial.

References

    1. Bigelow EO, Seiwert TY, Fakhry C. Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: current state and future directions. Oral Oncol. 2020;105:104652. doi: 10.1016/j.oraloncology.2020.104652. - DOI - PMC - PubMed
    1. Riaz N, Sherman E, Pei X, Schöder H, Grkovski M, Paudyal R, et al. Cancer. 2021 doi: 10.1093/jnci/djaa184. - DOI - PubMed
    1. Lock S, Perrin R, Seidlitz A, Bandurska-Luque A, Zschaeck S, Zophel K, et al. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging. Radiother Oncol. 2017;124:533–540. doi: 10.1016/j.radonc.2017.08.010. - DOI - PubMed
    1. Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012;105:21–28. doi: 10.1016/j.radonc.2012.08.019. - DOI - PubMed
    1. Nicolay NH, Rühle A, Wiedenmann N, Niedermann G, Mix M, Weber WA, et al. Lymphocyte infiltration determines the hypoxia-dependent response to definitive chemoradiation in head-and-neck cancer—results from a prospective imaging trial. J. Nucl Med. 2020 doi: 10.2967/jnumed.120.248633. - DOI - PMC - PubMed

LinkOut - more resources